Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats

Psychopharmacology

Volumn 156, Issue 1, 2001, Pages 108-114

  Rowland, N E ^a   Robertson, K ^a   Lo, J ^a   Rema, E ^a  

^a University of Florida ^*  (United States)

Author keywords

Anorectic agent; mCPP; Paraventricular hypothalamus; Receptor desensitization; Serotonin; TFMPP

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; DEXFENFLURAMINE; PHENYLPIPERAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN FOS; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CROSS TOLERANCE; FEMALE; IMMUNOREACTIVITY; MALE; NONHUMAN; PARABRACHIAL NUCLEUS; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR DOWN REGULATION; SOLITARY TRACT NUCLEUS;

ANIMALS; APPETITE DEPRESSANTS; DEXFENFLURAMINE; DRUG TOLERANCE; EATING; FEMALE; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0034939121     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100749     Document Type: Article

References (25)

1. Species differences in the kinetics and metabolism of fenfluramine isomers
2. Effects of initial body weight on anorexia and tolerance to fenfluramine in rats
3. Intermittent fenfluramine administration to rats suppresses food intake despite chronic brain serotonin suppression
4. 2 mechanisms of action
5. 2c receptor gene on meal patterns and on hypophagia induced by D-fenfluramine
6. Effect of chronic mCPP on locomotion, hypophagia, plasma corticosterone, and 5HT2C receptor levels in the rat
7. Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse in comparison with the rat
8. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons
9. D-fenfluramine and d-norfenfluramine-induced hypophagia: Differential mechanisms and involvement of postsynaptic 5-HT receptors
10. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons
11. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine
12. Tolerance to anorectic drugs: Pharmacological or artifactual
13. Dexfenfluramine induces Fos-like im-munoreactivity in discrete brain regions in rats
14. Effect of chronic dexfenfluramine on Fos in rat brain
15. Absence of fenfluramine induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid nucleus of serotonin 1B receptor knock-out mice
16. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: Importance of dose, species and drug
17. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain
18. Effect of continuous infusions of dexfenfluramine on food intake, body weight, and brain amines in rats
19. Tolerance to the anorectic effect of dexfenfluramine in rats: Role of serotonin, cholecystokinin, and neuropeptide Y
20. Neurobiology of an anorectic drug: Fenfluramine
21. Differences among "serotonergic" anorectics in a cross-tolerance paradigm: Do they all act on serotonin systems?
22. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions
23. Dexfenfluramine and norfenfluramine: Comparison of mechanism of action in feeding and brain Fos-ir studies
24. Comparative effects of continuous infusion of mCPP Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats
25. Effect of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetic, dose-response, regional specificity, and time course data